Where and how people with schizophrenia die: A population-based, matched cohort study in Manitoba, Canada

Journal of Clinical Psychiatry

Volumn 74, Issue 6, 2013, Pages

  Martens, Patricia J ^a   Chochinov, Harvey M ^b   Prior, Heather J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANADA; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GENERAL PRACTITIONER; GEOGRAPHY; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPITAL; HUMAN; ICD-10; ICD-9; ISCHEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; NURSING HOME; PALLIATIVE THERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY TRACT DISEASE; SCHIZOPHRENIA; SCHOOL CHILD; SUICIDE; TERMINAL CARE;

EID: 84879572955     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m08234     Document Type: Article

References (30)

1. Chwastiak LA, Tek C. The unchanging mortality gap for people with schizophrenia. Lancet. 2009;374(9690):590-592. doi:10.1016/S0140-6736(09)61072-2 PubMed
2. Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry. 1997;171(6):502-508. doi:10.192/bjp.171.6.502 PubMed
3. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123-1131. doi:10.101/archpsyc.64.10.123 PubMed
4. Tiihonen J, Lonnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620-627. doi:10.1016/S0140-6736(09)60742-X PubMed
5. Laursen TM, Munk-Olsen T, Nordentoft M, et al. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry. 2007;68(6):899-907. doi:10.408/JCP.v68n0612 PubMed
6. Brown S, Kim M, Mitchell C, et al. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry. 2010;196(2):116-121. doi:10.192/bjp.bp.109.067512 PubMed
7. Martens PJ, Chochinov HM, Prior HJ, et al; Need To Know Team. Are cervical cancer screening rates different for women with schizophrenia? a Manitoba population-based study. Schizophr Res. 2009;113(1):101-106. doi:10.1016/j.schres.209.04.015 PubMed
8. Chochinov HM, Martens PJ, Prior HJ, et al; Need To Know Team. Does a diagnosis of schizophrenia reduce rates of mammography screening? a Manitoba population-based study. Schizophr Res. 2009;113(1):95-100. doi:10.1016/j.schres. 209.04.02 PubMed
9. Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115-1121. doi:10.1016/j.ahj.205.02.07 PubMed
10. Straus SM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med. 2004;164(12):1293-1297. doi:10.101/archinte.164.12.1293 PubMed
11. Drici MD, Priori S. Cardiovascular risks of atypical antipsychotic drug treatment. Pharmacoepidemiol Drug Saf. 2007;16(8):882-890. doi:10.102/pds.1424 PubMed
12. Enger C, Weatherby L, Reynolds RF, et al. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis. 2004;192(1):19-27. doi:10.1097/01.nmd.010596.62105.07 PubMed
13. Wildgust HJ, Hodgson R, Beary M. The paradox of premature mortality in schizophrenia: new research questions. J Psychopharmacol. 2010;24(suppl):9-15. doi:10.17/1359786810382149 PubMed
14. Newcomer JW, Haupt DW. The metabolic effects of antipsychotic medications. Can J Psychiatry. 2006;51(8):480-491. PubMed
15. Martens P, Fransoo R, McKeen N, et al; Manitoba Centre for Health Policy. Patterns of regional mental illness disorder diagnoses and service use in Manitoba: a population-based study, September 2004. http://mchp-appserv. cpe.umanitoba.ca/reference/mental.health.pdf. Updated November 18, 2004. Accessed March 8, 2012.
16. Taylor JM. Choosing the number of controls in a matched case-control study, some sample size, power and efficiency considerations. Stat Med. 1986;5(1):29-36. doi:10.102/sim.478050106 PubMed
17. City of Winnipeg. Population of Winnipeg. March 16, 2012. http://winnipeg. ca/cao/pdfs/population.pdf. Accessed March 11, 2013.
18. Manitoba Health Population Report. Population of Brandon RHA, June 1, 2011. http://www.gov.mb.ca/health/population/3/brandon.pdf. Accessed March 11, 2013.
19. Chochinov HM, Martens PJ, Prior HJ, et al. Comparative health care use patterns of people with schizophrenia near the end of life: a population-based study in Manitoba, Canada. Schizophr Res. 2012;141(2-3):241-246. doi:10.1016/j.schres.2012.07.028 PubMed
20. Fransoo R, Martens P, Burland E. The Need to Know Team, Prior H, Burchill C. RHA Indicators Atlas 09 Data Extras. Manitoba Centre for Health Policy, September 2009. http://umanitoba.ca/faculties/medicine/units/community- health-sciences/departmental-units/mchp/projects/media/rha09-ch3-mortality-by- cause-sep17-09ab.xls. Accessed April 26, 2013.
21. Politi P, Piccinelli M, Klersy C, et al. Mortality in psychiatric patients 5 to 21 years after hospital admission in Italy. Psychol Med. 2002;32(2):227-237. doi:10.1017/S032917010516 PubMed
22. Kisely S, Sadek J, MacKenzie A, et al. Excess cancer mortality in psychiatric patients. Can J Psychiatry. 2008;53(11):753-761. PubMed
23. Dembling BP, Chen DT, Vachon L. Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv. 1999;50(8):1036-1042. PubMed
24. Hiroeh U, Kapur N, Webb R, et al. Deaths from natural causes in people with mental illness: a cohort study. J Psychosom Res. 2008;64(3):275-283. doi:10.1016/j.jpsychores.207.09.08 PubMed
25. Bushe CJ, Hodgson R. Schizophrenia and cancer: in 2010 do we understand the connection? Can J Psychiatry. 2010;55(12):761-767. PubMed
26. Lawrence D, Kisely S, Pais J. The epidemiology of excess mortality in people with mental illness. Can J Psychiatry. 2010;55(12):752-760. PubMed
27. Seale C. Death from cancer and death from other causes: the relevance of the hospice approach. Palliat Med. 1991;5(1):12-20. doi:10.17/0269216391050104
28. Hockley JM, Dunlop R, Davies RJ. Survey of distressing symptoms in dying patients and their families in hospital and the response to a symptom control team. Br Med J (Clin Res Ed). 1988;296(6638):1715-1717. doi:10.136/bmj.296.638. 1715 PubMed
29. Lynn J, Teno JM, Phillips RS, et al; SUPPORT Investigators, Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Perceptions by family members of the dying experience of older and seriously ill patients. Ann Intern Med. 1997;126(2):97-106. PubMed
30. Viron MJ, Stern TA. The impact of serious mental illness on health and healthcare. Psychosomatics. 2010;51(6):458-465. PubMed